Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Industry
Pharmaceutical Preparations
Location
9237 E Via De Ventura Blvd., Suite 105, Scottsdale, AZ
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 133 % +49.1%
Quick Ratio 32.8 % +65.6%
Debt-to-equity 400 % -31.3%
Return On Equity -106 % -212%
Return On Assets -21.3 % -325%
Operating Margin -24.4 % -831%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 50.1M USD +309%
Weighted Average Number of Shares Outstanding, Basic 20.4M shares +12.1%
Weighted Average Number of Shares Outstanding, Diluted 20.4M shares +12.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 56.1M USD -29.1%
Revenue from Contract with Customer, Excluding Assessed Tax 55.1M USD -7.59%
Cost of Revenue 20.9M USD -8.8%
Research and Development Expense 9.86M USD +30.7%
Costs and Expenses 69.8M USD -14.1%
Operating Income (Loss) -13.7M USD -560%
Nonoperating Income (Expense) -934K USD +40.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.6M USD -302%
Income Tax Expense (Benefit) 95K USD +850%
Net Income (Loss) Attributable to Parent -14.7M USD -281%
Earnings Per Share, Basic -0.72 USD/shares -243%
Earnings Per Share, Diluted -0.72 USD/shares -243%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 20.3M USD -26%
Accounts Receivable, after Allowance for Credit Loss, Current 10.2M USD -32.8%
Inventory, Net 14.4M USD +41.4%
Assets, Current 48.2M USD -14.7%
Operating Lease, Right-of-Use Asset 199K USD +97%
Intangible Assets, Net (Excluding Goodwill) 31.9M USD +57.1%
Other Assets, Noncurrent 6K USD 0%
Assets 80.2M USD +4.41%
Accounts Payable, Current 16.1M USD -11.6%
Accrued Liabilities, Current 17.4M USD -14.4%
Liabilities, Current 35.2M USD -16%
Operating Lease, Liability, Noncurrent 118K USD +1211%
Liabilities 60.2M USD +6.5%
Retained Earnings (Accumulated Deficit) -87M USD -20.3%
Stockholders' Equity Attributable to Parent 20.1M USD -1.38%
Liabilities and Equity 80.2M USD +4.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.02M USD -425%
Net Cash Provided by (Used in) Financing Activities 1.64M USD +3048%
Net Cash Provided by (Used in) Investing Activities -5M USD +75%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.38M USD +42.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 20.3M USD -26%
Interest Paid, Excluding Capitalized Interest, Operating Activities 267K USD -50.1%
Deferred Tax Assets, Valuation Allowance 24M USD +19.3%
Deferred Tax Assets, Gross 24.1M USD +19.4%
Operating Lease, Liability 201K USD +86.1%
Lessee, Operating Lease, Liability, to be Paid 217K USD +95.5%
Operating Lease, Liability, Current 83K USD -16.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 105K USD +1067%
Lessee, Operating Lease, Liability, to be Paid, Year One 94K USD -7.84%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16K USD +433%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.81M USD +55.7%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 107M USD +15.5%
Amortization of Intangible Assets 814K USD -23.9%
Deferred Tax Assets, Net of Valuation Allowance 50K USD +100%
Share-based Payment Arrangement, Expense 6.1M USD +134%
Interest Expense 1.6M USD -30%